| Literature DB >> 23050150 |
Odutola Israel Odetunde1, Oluwatoyin Arinola Odetunde, Adesoji Oludotun Ademuyiwa, Henrietta Uche Okafor, Uchenna Ekwochi, Jonathan Chukwuemeka Azubuike, Nene Elsie Obianyo.
Abstract
Delayed presentation of patients with posterior urethral valve with complications like severe urosepsis, uremia, and anemia are seen in our setting. Renal replacement therapy which should have been offered to these patients is not readily available for children in our country. The aim of this study is to determine the pattern of late presentation and outcome of management of posterior urethral valve in a resource-limited setting. A descriptive retrospective study (1997-2009) was conducted. Data including pattern of presentation, duration of symptoms, complications, and outcome of initial management were analyzed. Twenty-one patients were seen. The median age was 3 years (2 days-13 years). The mean duration of symptoms before presentation was 2.6 years. Nineteen patients (91%) presented with urosepsis while 8 patients (36%) presented with significant renal insufficiency. Laboratory findings varied from-mild-to marked elevation in serum creatinine. Radiological findings confirmed the diagnosis of posterior urethral valve. We concluded that late presentation is common in our setting. This is associated with high morbidity and mortality rates. Efforts at improving awareness and early diagnosis among the health team should be made to stem the tide.Entities:
Year: 2012 PMID: 23050150 PMCID: PMC3459254 DOI: 10.1155/2012/345298
Source DB: PubMed Journal: Int J Nephrol
Figure 1Age distribution of patients at presentation.
Age distribution of patients and clinical features at presentation.
| Age group |
| Voiding abnormality | Recurrent fever | Ballotable kidney | Palpable bladder | Failure to thrive | Others |
|---|---|---|---|---|---|---|---|
| <1 month | 2 (9.5) | 2 (9.5) | 0 (0.0) | 1 (4.8) | 1 (4.8) | 0 (0.0) | 0 (0.0) |
| 1 month–1 year | 8 (38.1) | 8 (38.1) | 8 (38.1) | 3 (14.3) | 4 (19.1) | 0 (0.0) | 0 (0.0) |
| 1–5 years | 7 (33.3) | 7 (33.3) | 7 (33.3) | 7 (33.3) | 7 (33.3) | 3 (14.3) | 6 (28.6) |
| >5 years | 4 (19.1) | 4 (19.1) | 4 (19.1) | 4 (19.1) | 4 (19.1) | 3 (14.3) | 4 (19.1) |
|
| |||||||
| Total | 21 (100) | 21 (100) | 19 (90.5) | 15 (71.4) | 16 (76.2) | 6 (28.6) | 10 (47.6) |
Figure 2Patients with severe renal failure and required renal replacement therapy (RRT) at presentation.